HCSGD entry for PRIMA1


1. General information

Official gene symbolPRIMA1
Entrez ID145270
Gene full nameproline rich membrane anchor 1
Other gene symbolsPRIMA
Links to Entrez GeneLinks to Entrez Gene

2. Neighbors in the network

color bar

3. Gene ontology annotation

GO ID

GO term

Evidence

Category

GO:0016021Integral component of membraneIEAcellular_component
GO:0019899Enzyme bindingIEAmolecular_function
GO:0030054Cell junctionIEAcellular_component
GO:0031226Intrinsic component of plasma membraneIEAcellular_component
GO:0042135Neurotransmitter catabolic processIEAbiological_process
GO:0043495Protein anchorIEAmolecular_function
GO:0045202SynapseIEAcellular_component
GO:0051649Establishment of localization in cellIEAbiological_process
Entries Per Page
Displaying Page of

4. Expression levels in datasets

  • Meta-analysis result

p-value upp-value downFDR upFDR down
0.68703915500.81984015800.99999024731.0000000000

  • Individual experiment result
    ( "-" represent NA in the specific microarray platform )

Data sourceUp or downLog fold change
GSE11954Down-0.0302427814
GSE13712_SHEARUp0.1129334785
GSE13712_STATICUp0.0710921715
GSE19018Up0.0558097196
GSE19899_A1Up0.0099528591
GSE19899_A2Up0.1673373929
PubMed_21979375_A1Up0.0610793708
PubMed_21979375_A2Down-0.0185839612
GSE35957Up0.1754323174
GSE36640Down-0.0210557948
GSE54402Down-0.0544794976
GSE9593Down-0.0955706884
GSE43922Up0.0233788462
GSE24585Down-0.0600102763
GSE37065Down-0.0704653139
GSE28863_A1Down-0.1355557108
GSE28863_A2Down-0.0556986265
GSE28863_A3Up0.3878564010
GSE28863_A4Up0.0700784541
GSE48662Up0.0179717238

5. Regulation relationships with compounds/drugs/microRNAs

  • Compounds

Not regulated by compounds

  • Drugs

Not regulated by drugs

  • MicroRNAs

  • mirTarBase

MiRNA_name

mirBase ID

miRTarBase ID

Experiment

Support type

References (Pubmed ID)

hsa-miR-1MIMAT0000416MIRT023651MicroarrayFunctional MTI (Weak)18668037
Entries Per Page
Displaying Page of
  • mirRecord
No target information from mirRecord

6. Text-mining results about the gene

Gene occurances in abstracts of cellular senescence-associated articles: 2 abstracts the gene occurs.


PubMed ID of the article

Sentenece the gene occurs

24804545PRIMA-1 selectively induces global DNA demethylation in p53 mutant-type thyroid cancer cells
24804545Recently, the identification of mutant p53-reactivating small molecules such as PRIMA-1 (p53 reactivation and induction of massive apoptosis) renders possibilities for the development of more efficient anticancer drugs
24804545Although PRIMA-1 has been widely used for cancer therapy and exhibits a promising anticancer activity, its biological effect, particularly the epigenetic aspect, remains to be well elucidated
24804545The present study attempts to explore the effect of PRIMA-1 on DNA methylation in a panel of thyroid cancer cell lines using luminometric methylation assay (LUMA)
24804545Our results showed that only p53 mutant-type cells were inhibited upon PRIMA-1 treatment
24804545Conversely, p53 wild-type cells were non-sensitive to PRIMA-1
24804545Moreover, our data demonstrated that PRIMA-1 selectively induced significant global DNA demethylation in p53 mutant-type cells
24804545Mechanically, PRIMA-1 induced global DNA demethylation in these cells mainly through inhibiting the expression of DNA methyltransferase (DNMT) 1, 3a and 3b, and upregulating the expression of GADD45a
24804545Notably, PRIMA-1 dramatically increased the expression of the ten-eleven translocation (TET) family of 5mC-hydroxylases, particularly TET1, in p53 mutant-type cells, further contributing to DNA demethylation
24804545Thus, this study uncovered a previously unrecognized and prominent biological effect of PRIMA-1 through which it can cause global DNA demethylation in p53 mutant-type cancer cells mainly by rescuing the function of mutant p53 protein
20498645The compound PRIMA-1 (p53 reactivation and induction of massive apoptosis) restores wild-type conformation to mutant p53 by binding to the core and induces apoptosis in human tumor cells
20498645The PRIMA-1 analog APR-246 is currently tested in a clinical trial
Entries Per Page
Displaying Page of